Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.
about
Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuriesEthyl Pyruvate: An Anti-Microbial Agent that Selectively Targets Pathobionts and BiofilmsHMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.IDO is a nodal pathogenic driver of lung cancer and metastasis development.Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotionIDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancerIndoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formationThe Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1IDO1 is an Integral Mediator of Inflammatory Neovascularization.Modulation of tumor tolerance in primary central nervous system malignancies.Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.Shaping the glioma immune microenvironment through tryptophan metabolism.Immunomodulating effect of ethyl pyruvate on nonsyngenic transplanted tumor in mice.Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis.Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer.Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase.Specific in situ detection of murine indoleamine 2, 3-dioxygenase.Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation.Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer.Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer.Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors.1-Methyl-D-tryptophan Reduces Tumor CD133+ cells, Wnt/β-catenin and NF-κβp65 while Enhances Lymphocytes NF-κβ2, STAT3, and STAT4 Pathways in Murine Pancreatic Adenocarcinoma.Novel β-phenylacrylic acid derivatives exert anti-cancer activity by inducing Src-mediated apoptosis in wild-type KRAS colon cancer
P2860
Q28068263-AE60A17F-8F05-469D-9F39-26072E7F6863Q28554303-B5D733FE-5F03-4664-9B24-4DAF2BF8E376Q33618428-AD731F4B-D5F7-46C7-B847-C8BF50A0064AQ34289698-0BDEF15F-6B25-4663-BC44-E0FA38275C7FQ34393455-C023C2AF-2A0C-4270-B8B7-73FB4FC9B322Q34396547-D1398835-A569-4745-9A72-F3BD1EE575B3Q34414152-D7D871F0-B2EC-439F-86AD-48C31788647EQ35261110-1A902CCB-0E05-4476-913B-106FB60629C9Q35739397-84049755-122B-49D8-BB7B-15AB5A73F14DQ35753251-2E8E8A34-BDC1-45F2-978E-1A5F5AD18D4BQ35986384-DE2F79A1-B4A1-4AC3-82CF-5DE092510FA5Q37146296-F46C613E-5A86-41C6-A64F-1DE123710A16Q37510171-514D8C9F-19CA-4650-BF5E-C9A4341A8470Q37982065-BBEC82AE-E9CC-4772-BCAC-D1AC0D977BE3Q38047057-8B54D95D-A0E6-4A69-B956-B9E422570B38Q38233070-992AD135-2649-4BD1-9899-C414036B98EAQ39052137-3528798F-326B-4DAC-A0F2-9D32FCF80F20Q39214419-6E5DB593-2C0A-437B-A2F0-B887A0B015D4Q39478032-279BAE91-38F7-49F6-B934-1C7BD7446EEAQ39695809-05937B98-BB3C-476F-9C64-0983F6CD22F1Q39956064-2ED9D5AC-7788-4CCD-96A9-F5B174B0C354Q42734436-6A131061-4DA0-41ED-B711-75CBAECA8939Q46022555-466EFEF8-78D6-4871-84F8-A8354EABE744Q50136955-0B9EFAEF-BC2B-47C8-982B-700CBEA084EEQ55346219-DE419C07-4D04-415D-89D2-AB4343B3D1B1Q55516059-91496E19-B6A1-4A01-899C-1B150FD36C66Q58695691-D5A47BA5-0327-4B05-8161-37A848607A7B
P2860
Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immunotherapeutic suppression ...... or growth with ethyl pyruvate.
@ast
Immunotherapeutic suppression ...... or growth with ethyl pyruvate.
@en
type
label
Immunotherapeutic suppression ...... or growth with ethyl pyruvate.
@ast
Immunotherapeutic suppression ...... or growth with ethyl pyruvate.
@en
prefLabel
Immunotherapeutic suppression ...... or growth with ethyl pyruvate.
@ast
Immunotherapeutic suppression ...... or growth with ethyl pyruvate.
@en
P2093
P2860
P1433
P1476
Immunotherapeutic suppression ...... or growth with ethyl pyruvate.
@en
P2093
Alexander J Muller
Daniel Jaller
George C Prendergast
James B DuHadaway
Peter Curtis
Richard Metz
P2860
P304
P356
10.1158/0008-5472.CAN-09-3613
P407
P577
2010-02-16T00:00:00Z